+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Adrenocortical Carcinoma- Pipeline Insight, 2025 - Product Thumbnail Image

Adrenocortical Carcinoma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Adenoid Cystic Carcinoma- Pipeline Insight, 2025 - Product Thumbnail Image

Adenoid Cystic Carcinoma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Advanced Pancreatic Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Pancreatic Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Advanced Liver Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Liver Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Advanced Recurrent Ovarian Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Recurrent Ovarian Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Adult T-Cell Leukemia-Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Adult T-Cell Leukemia-Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Thymoma - Pipeline Insight, 2025 - Product Thumbnail Image

Thymoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Brain Metastases- Pipeline Insight, 2025 - Product Thumbnail Image

Brain Metastases- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 220 Pages
  • Global
From
Richter's Syndrome- Pipeline Insight, 2025 - Product Thumbnail Image

Richter's Syndrome- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
CCR5 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

CCR5 Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
PI3K Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

PI3K Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 150 Pages
  • Global
From
From
Eg5 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Eg5 Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
RON (Recepteur D'origine Nantais) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

RON (Recepteur D'origine Nantais) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Heat Shock Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Heat Shock Protein Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Bcr-Abl Tyrosine Kinase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Bcr-Abl Tyrosine Kinase Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Sphingosine 1-Phosphate (S1P) Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Sphingosine 1-Phosphate (S1P) Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Murine Double Minute 2 (MDM2) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Murine Double Minute 2 (MDM2) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Transforming Growth Factor Beta Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Transforming Growth Factor Beta Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 150 Pages
  • Global
From
TIM-3 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

TIM-3 Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more